Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

NICE Announces Review Of Its Skin Cancer Guidance
The National Institute for Health and Clinical Excellence (NICE) has announced that it will convene a guidance development group to formally review the recommendations relating to the diagnosis and removal of "low risk" basal cell carcinomas (BCCs) in primary care in its guidance Improving Outcomes in Cancer for people with skin tumours including melanoma (2003).
generic viagra online
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) For The Treatment Of Fabry Disease
Amicus Therapeutics (Nasdaq: FOLD) announced it has commenced the U.S. registration Phase 3 trial with its investigational drug, Amigal(TM) (migalastat hydrochloride) for the treatment of Fabry disease. The Company has reached agreement with the U.S. Food and Drug Administration (FDA) on the key protocol design elements of the pivotal trial, including the use of the surrogate primary endpoint of the change in the amount of kidney interstitial capillary GL-3, the substrate that accumulates in the cells of Fabry patients. In addition, the FDA is in agreement that the Company is eligible to seek Accelerated Approval for Amigal according to Subpart H regulations. The Company has begun submitting the Phase 3 protocol to investigational sites worldwide and expects to begin the dosing of subjects in the second half of this year.
News of the day
Who Director General Calls For Fairness In International Policies
New York: With a growing recognition that "blind faith in economic growth and gain as the be-all, end-all, cure-for-all has been misplaced," World Health Organization Director-General Dr Margaret Chan responded to leaders who have been calling for a redesign of international systems.
Oncology

SCRIP's 'Best-In-Class' Reporting Recognised By Industry - Journalist Malani Guha Wins Advances In Renal Cancer Journalists' Award

Journalist, Malini Guha, has won the prestigious new Advances in Renal Cancer Journalists" Award - Europe for her article "New Advances Deliver Fresh Hope in Kidney Cancer" - which was published in Scrip World Pharmaceutical News on February 13th 2009. The award was presented by the esteemed Association of German Medical Journalists (VDMJ) at this month"s Fourth European International Kidney Cancer Symposium in Berlin. In her article, Malini Guha - Science Editor at Scrip - provides a concise and informative review of the current options and prospects of success in the treatment of renal cell carcinoma. "It is a great honour to be the first-ever recipient of this award," says Malini. "My article focused on the significant progress made in the treatment of kidney cancer in recent years and also examined the outlook for other approaches which may further improve patient outcomes." The jury - comprising Professor Peter Mulders, Department of Urology, University Medical Center St Radboud, Nijmwegan in the Netherlands; Dr Bernard Escudier, Institut Gustave Roussy, Villejuif in France; and Torsten Hoffman, President of the VdMJ, Stuttgart in Germany - evaluated submissions from print media and were highly complimentary of Malini"s work. The panel said: "The article comes across as both scientifically accurate and clearly comprehensible, aiming to give interested readers the necessary information on the latest research into treatment in this indication in a manner that is comprehensive and yet not overtaxing. "Guha"s writing adheres to the guiding principle of medical journalism: "do not stir up anxiety and do not raise unreasonable hopes." The article is a testament to the detailed investigative work conducted by Malini Guha herself at research centers, hospitals and amongst specialist oncologists. This, too, is a mark of good journalistic practice. Furthermore, the journalist"s own personal interest in the subject matter also contributes to the success of this commendable publication." "We are delighted that Malini"s work has been recognised so publicly in the form of this highly prestigious award," says Phil Jarvis, Publisher of Scrip World Pharmaceutical News. "It is a testament to her talent, hard work and vast knowledge of the subject matter and we are extremely proud to have published her work in Scrip." The Advances in Renal Cancer Journalists" Award - Europe was sponsored by Bayer Healthcare AG and was presented to Malini Guha on May 8th, 2009. Scrip World Pharmaceutical News


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009